Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 053566/0916 | |
| Pages: | 5 |
| | Recorded: | 08/21/2020 | | |
| Attorney Dkt #: | 4239-100408-06 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16971288
|
Filing Dt:
|
08/19/2020
|
|
Publication #:
|
|
Pub Dt:
|
01/14/2021
| | | | |
|
Title:
|
USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION
|
|
|
Assignee
|
|
|
|
|
| 6011 EXECUTIVE BOULEVARD, SUITE 325, MSC 7660 |
| NATIONAL INSTITUTES OF HEALTH |
| BETHESDA, MARYLAND 20892-7660 |
|
|
Correspondence name and address
|
| |
KLARQUIST SPARKMAN, LLP
|
| |
121 SW SALMON ST
|
| |
SUITE 1600
|
| |
PORTLAND, OR 97204-2908
|
Search Results as of:
05/28/2024 12:37 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
